We took two different approaches to infection: a therapeutic study, where we administered hepcidin after infection, and a prophylactic study, where we administered hepcidin before infection, to evaluate both the potential to treat and prevent bacterial diseases, in this case pasteurelosis, caused by Photobacterium damsela spp. The gene discussed is HAMP; the disease is bacterial infectious disease.